How Games Workshop, Fever-Tree and YouGov became small-cap legends

The thing that most market commentators get wrong about small-cap success stories is that they tend to look obvious in hindsight. You read about a company that turned a modest investment into a life-changing return over a decade and you think: how could anyone have missed that? The answer, almost always, is that it was perfectly easy to miss. The companies that deliver extraordinary long-term returns from small-cap beginnings are rarely the ones that announce themselves loudly. They tend to be boring, niche, under-followed, and frequently misunderstood. Games Workshop, Fever-Tree and YouGov are three of the clearest illustrations of this pattern from UK market history.

Games Workshop is the standout. The Nottingham-based maker of Warhammer figurines spent the better part of two decades being dismissed as a hobby shop that happened to be listed on the stock exchange. For years the shares traded at levels that suggested investors saw no particular future in miniature paint and plastic warriors. The company had a passionate customer base but a limited audience, and the prevailing view was that the hobbyist market had a ceiling. That view turned out to be spectacularly wrong. What the critics had missed was that Games Workshop had something most small-cap companies never achieve: genuine pricing power, a loyal community that functioned almost like a recurring revenue stream, and a management team that was quietly allocating capital with real discipline. The company kept margins tight, refused to chase growth for its own sake, and built an intellectual property estate that eventually attracted licensing interest from game developers and streaming platforms. By the time the broader market caught on, the shares had moved from well under 100p to above 12,000p. Games Workshop graduated from AIM to the Main Market of the London Stock Exchange in 2019 and joined the FTSE 100 in 2022. Investors who held through the lean years of the early 2000s experienced something rarely available in public markets: a genuine compounder bought at small-cap prices.

Fever-Tree followed a different path but the underlying logic was the same. The premium mixer company floated on AIM in 2014 at 134p per share. The idea seemed straightforward: premium spirits deserved premium mixers, and the tonic water market had been neglected for decades. But the float attracted scepticism. Would people really pay significantly more for a tonic? Was this a real product or a fashionable fad? The founders had conviction and the numbers backed them up. Fever-Tree grew revenues at exceptional rates through the mid-2010s as the gin boom gathered pace across the UK and Europe. The shares peaked above 4,000p in late 2018, representing a return that few investors who bought at float would ever have forecast. Since then the picture has been more complicated. The cost environment became difficult, growth slowed and the shares retraced significantly from those highs. That part of the story is also instructive. Fever-Tree demonstrated both what small-cap success looks like when it is working and the importance of monitoring valuations carefully when sentiment runs ahead of fundamentals. At peak pricing, the stock demanded perfection. Markets rarely allow that luxury for long. The company remains listed on AIM and continues to operate, but the lesson from the later years is as valuable as the lesson from the early ones.

YouGov offers a different kind of story again. The polling and data analytics business floated on AIM in 2005 and spent years being filed under interesting but unclear by most institutional investors. The core question was always whether the subscription data model would scale and whether online panels could be trusted as a research methodology at a time when market research was still largely telephone-based. The answer came slowly and then all at once. YouGov built out a genuinely global operation, signed long-term contracts with media organisations and corporate clients, and developed a proprietary brand tracking product that became something like a standard reference for marketers. The shares moved from low double digits at float to above 1,000p at peak, though like Fever-Tree they have retraced from those highs in more recent years. What YouGov built that mattered was a data moat. The panel data accumulated over years cannot easily be replicated by a new entrant, and that structural advantage underpinned a valuation premium for a long time. Investors who identified that early and held patiently saw returns that would have been impossible to generate in large-cap markets.

The pattern that connects all three is not complicated to describe, though it is genuinely difficult to act on. Each company had a niche that looked small from the outside and turned out to be larger than almost anyone expected. Each had management that thought in years rather than quarters. Each was generating real earnings at the point when it was cheapest, not simply telling a story about future revenues. And each was ignored by most institutional investors for long enough that patient private investors had time to build meaningful positions at prices that reflected genuine uncertainty rather than confidence.

None of these companies announced themselves as future success stories. Games Workshop sold plastic soldiers. Fever-Tree sold tonic water. YouGov ran online polls. The market will always discount businesses it cannot easily categorise, and the edge for investors willing to do the work is that the discounting is often severe. Identifying a company with real earnings, durable competitive advantages and management that thinks long-term before the institutional money arrives is the closest thing this market offers to a systematic edge. These three case studies show what that looks like when it works.

This post is drawn from The Little Book of Small-Caps by Cameron Oliver. Republished with permission.

Small Caps is a series drawn from first-hand experience of UK and global small-cap markets, updated as each new chapter arrives.

Disclaimer: The value of investments can go down as well as up, and you may get back less than you invest. This article is for informational and educational purposes only and does not constitute financial advice. Always do your own research and consider seeking independent advice before making any investment decision.